Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Pharma (IGC) over the last 17 years, with Q3 2025 value amounting to $5000.0.

  • Pharma's Exchange Rate Effect rose 14545.45% to $5000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $32000.0, marking a year-over-year increase of 63333.33%. This contributed to the annual value of -$7000.0 for FY2025, which is 1666.67% down from last year.
  • Pharma's Exchange Rate Effect amounted to $5000.0 in Q3 2025, which was up 14545.45% from $25000.0 recorded in Q2 2025.
  • Pharma's 5-year Exchange Rate Effect high stood at $25000.0 for Q2 2025, and its period low was -$52000.0 during Q2 2022.
  • Over the past 5 years, Pharma's median Exchange Rate Effect value was $1000.0 (recorded in 2023), while the average stood at -$5111.1.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first crashed by 390000.0% in 2022, then skyrocketed by 115000.0% in 2025.
  • Over the past 5 years, Pharma's Exchange Rate Effect (Quarter) stood at $14000.0 in 2021, then crashed by 192.86% to -$13000.0 in 2022, then surged by 107.69% to $1000.0 in 2023, then crashed by 1200.0% to -$11000.0 in 2024, then skyrocketed by 145.45% to $5000.0 in 2025.
  • Its Exchange Rate Effect stands at $5000.0 for Q3 2025, versus $25000.0 for Q2 2025 and $2000.0 for Q1 2025.